Flavoxate HCL
Flavoxate HCL Brand names, Flavoxate HCL Analogs
Flavoxate HCL Brand Names Mixture
- No information avaliable
Flavoxate HCL Chemical_Formula
C58H73N7O17
Flavoxate HCL RX_link
No information avaliable
Flavoxate HCL fda sheet
Flavoxate HCL msds (material safety sheet)
Flavoxate HCL Synthesis Reference
No information avaliable
Flavoxate HCL Molecular Weight
1140.24 g/mol
Flavoxate HCL Melting Point
No information avaliable
Flavoxate HCL H2O Solubility
Practically insoluble
Flavoxate HCL State
Solid
Flavoxate HCL LogP
0.216
Flavoxate HCL Dosage Forms
Injection (50 mg vials to be reconstituted prior to injection)
Flavoxate HCL Indication
For use in the treatment of the following fungal infections: Candidemia and other forms of Candida infections (intra-abdominal abscess, and peritonitis) and esophageal candidiasis.
Flavoxate HCL Pharmacology
Anidulafungin is a semi-synthetic lipopeptide synthesized from a fermentation product of Aspergillus nidulans. Anidulafungin is an echinocandin, a class of antifungal drugs that inhibits the synthesis of 1,3-β-D-glucan, an essential component of fungal cell walls. Anidulafungin is active in vitro against Candida albicans, C. glabrata, C. parapsilosis, and C. tropicalis.
Flavoxate HCL Absorption
No information avaliable
Flavoxate HCL side effects and Toxicity
During clinical trials a single 400 mg dose of anidulafungin was inadvertently administered as a loading dose. No clinical adverse events were reported. The maximum non-lethal dose of anidulafungin in rats was 50 mg/kg, a dose which is equivalent to 10 times the recommended daily dose for esophageal candidiasis (50mg/day).
Flavoxate HCL Patient Information
Flavoxate HCL Organisms Affected
Aspergillis, Candida and other fungi
